Vimarsana
Biggest News Aggregation in the World

Artms Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Artms Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Artms Inc Today - Breaking & Trending Today

Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy - Vimarsana News

Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy

ROCHESTER, Minn.--(BUSINESS WIRE)--Dec 7, 2023--

ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets - Vimarsana News

ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets

ARTMS Inc. and Isotopia Molecular Imaging ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets Wednesday, January 20, 2021 11:00AM IST (5:30AM GMT)   ARTMS Inc. (ARTMS) and Isotopia Molecular Imaging (Isotopia) are pleased to announce the successful radiolabeling of Isotopia’s prostate cancer imaging kit product, PSMA-11, with over 2 Ci of cyclotron-produced Gallium-68 ( 68Ga) using ARTMS’ proprietary Quantum Irradiation System™ (QIS™) solid target system.  ...

ARTMS and Telix Pharmaceuticals Announce Successful Production of PSMA-11 with Cyclotron Produced 68Ga from a Solid Target - Vimarsana News

ARTMS and Telix Pharmaceuticals Announce Successful Production of PSMA-11 with Cyclotron Produced 68Ga from a Solid Target

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Health Canada Approves Cyclotron Produced Technetium-99m utilizing the ARTMS QIS and Solid Targets - Vimarsana News

Health Canada Approves Cyclotron Produced Technetium-99m utilizing the ARTMS QIS and Solid Targets

ARTMS Inc. (ARTMS) is excited to announce Health Canada’s marketing approval of cyclotron produced technetium-99m ( 99mTc) for clinical use. For the Health Canada submission, ARTMS provided technical expertise and the solid targets required for production to a Canadian consortium consisting of BC Cancer, TRIUMF, Lawson Health Research and the Centre for Probe Development and Commercialization. The process was approved by Health Canada on November 26, 2020 and is being deployed immediately. “The Nuclear Medicine community and our patients have seen multiple supply chain challenges with 99...